{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:05:27Z","timestamp":1785769527751,"version":"3.56.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Accurate staging is essential in high risk breast cancer to guide management. While flurodeoxyglucose (FDG) PETCT is well established, limited data exist on the cancers role of maximum standardized uptake value (SUV\n                      <jats:sub>max<\/jats:sub>\n                      ) and diffusion-weighted imaging (DWI), especially with limited access to positron emission tomography and magnetic resonance imaging (PETMR). This study evaluates the diagnostic performance of PETMR and correlation between SUV\n                      <jats:sub>max<\/jats:sub>\n                      and apparent diffusion coefficient (ADC) values in staging these patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study includes 76 biopsy-confirmed treatment-na\u00efve high risk breast cancer patients (triple negative breast cancer and non-triple negative breast cancer) who underwent FDG PETMR (2021\u20132024). A total of 965 lesions were analysed. Lesion detection, quantitative parameters, and diagnostic performance were assessed, including receiver operating characteristic analysis of SUV\u2013ADC biomarkers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      SUV\n                      <jats:sub>max<\/jats:sub>\n                      showed an inverse correlation with ADC\n                      <jats:sub>mean<\/jats:sub>\n                      (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      \u2005=\u2005\u20130.41) and ADC\n                      <jats:sub>min<\/jats:sub>\n                      (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      \u2005=\u2005\u20130.47), strongest in primary breast tumours and skeletal metastases. The SUV\n                      <jats:sub>max<\/jats:sub>\n                      \/ADC\n                      <jats:sub>min<\/jats:sub>\n                      ratio effectively graded tumours and correlated with Ki-67 (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      \u2005=\u20050.55). FDG PET demonstrated higher specificity (87.8%) than DWI (82.7%), while DWI was more sensitive for detecting small lesions. False positives and false-negative lesions were identified by correlating PET and DWI findings with histopathology (wherever available) or using follow up imaging.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Simultaneous PETMR is promising for accurate staging of high risk breast cancer. PET demonstrates higher specificity, whereas DWI improves sensitivity for detecting smaller lesions, particularly in liver, brain, and lungs. A combined FDG PET DWI approach enhances overall diagnostic accuracy and improves lesion characterization and staging. Additionally, the combination of SUV\n                      <jats:sub>max<\/jats:sub>\n                      and Ki-67 provides a reliable indicator of tumour aggressiveness.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mnm.0000000000002156","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:02:20Z","timestamp":1775815340000},"page":"975-985","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Added value of maximum standardized uptake value and diffusion-weighted imaging in staging of high risk breast cancer patients using simultaneous 18F-flurodeoxyglucose positron emission tomography and magnetic resonance imaging"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3550-1756","authenticated-orcid":false,"given":"Padma","family":"Subramanyam","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine & Molecular Imaging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3114-4256","authenticated-orcid":false,"given":"Shanmuga Sundaram","family":"Palaniswamy","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine & Molecular Imaging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibiraj Hemant","family":"Patel","sequence":"additional","affiliation":[{"name":"Amrita Institute of Medical Sciences, Amrita Vishwavidyapeetham, Cochin, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"R1-20260708","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1593\/neo.81328","article-title":"Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.","volume":"11","author":"Padhani","year":"2009","journal-title":"Neoplasia"},{"key":"R2-20260708","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1259\/bjr\/81090732","article-title":"Analysis of MR diffusion weighted images.","volume":"77 Spec No 2","author":"Parker","year":"2004","journal-title":"Br J Radiol"},{"key":"R3-20260708","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.mric.2010.10.007","article-title":"Diffusion-weighted magnetic resonance imaging for the evaluation of musculoskeletal tumors.","volume":"19","author":"Costa","year":"2011","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"R4-20260708","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2463\/mrms.3.79","article-title":"Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value.","volume":"3","author":"Kuroki","year":"2004","journal-title":"Magn Reson Med Sci"},{"key":"R5-20260708","doi-asserted-by":"crossref","first-page":"e13928","DOI":"10.1002\/acm2.13928","article-title":"Assessing the variability and correlation between SUV and ADC parameters of head and neck cancers derived from simultaneous PET\/MRI: a single-center study.","volume":"24","author":"Wongsa","year":"2023","journal-title":"J Appl Clin Med Phys"},{"key":"R6-20260708","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4329\/wjr.v8.i9.785","article-title":"Diffusion weighted imaging: technique and applications.","volume":"8","author":"Baliyan","year":"2016","journal-title":"World J Radiol"},{"key":"R7-20260708","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jmri.21884","article-title":"Diffusion-weighted imaging of breast cancer: Correlation of the apparent diffusion coefficient value with prognostic factors.","volume":"30","author":"Kim","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"R8-20260708","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1007\/s00259-021-05502-0","article-title":"Comparison of nodal staging between CT, MRI, and [18F]-FDG PET\/MRI in patients with newly diagnosed breast cancer.","volume":"49","author":"Morawitz","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R9-20260708","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00259-010-1640-9","article-title":"Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.","volume":"38","author":"Groheux","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R10-20260708","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/jmri.22608","article-title":"Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis.","volume":"34","author":"Wu","year":"2011","journal-title":"J Magn Reson Imaging"},{"key":"R11-20260708","doi-asserted-by":"crossref","first-page":"3417190","DOI":"10.1155\/2018\/3417190","article-title":"Is SUVmax Helpful in the Differential Diagnosis of Enlarged Mediastinal Lymph Nodes? A Pilot Study.","volume":"2018","author":"Yu","year":"2018","journal-title":"Contrast Media Mol Imaging"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MNM.0000000000002156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:15:24Z","timestamp":1785766524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MNM.0000000000002156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000002156","relation":{},"ISSN":["0143-3636","1473-5628"],"issn-type":[{"value":"0143-3636","type":"print"},{"value":"1473-5628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"2026-01-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}